Cadrenal Therapeutics Announces New Chief Medical Officer in Recent SEC Filing
Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025. The company detailed the appointment of Dr. James J. Ferguson III as its new Chief Medical Officer. Dr. Ferguson, an esteemed industry expert with over […]
Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025. The company detailed the appointment of Dr. James J. Ferguson III as its new Chief Medical Officer. Dr. Ferguson, an esteemed industry expert with over […]
